mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |